FR2987267B1 - APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES - Google Patents
APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANESInfo
- Publication number
- FR2987267B1 FR2987267B1 FR1200581A FR1200581A FR2987267B1 FR 2987267 B1 FR2987267 B1 FR 2987267B1 FR 1200581 A FR1200581 A FR 1200581A FR 1200581 A FR1200581 A FR 1200581A FR 2987267 B1 FR2987267 B1 FR 2987267B1
- Authority
- FR
- France
- Prior art keywords
- cacanomanes
- modafinil
- substitution
- treatment
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Priority Applications (33)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1200581A FR2987267B1 (en) | 2012-02-28 | 2012-02-28 | APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES |
EP13715263.3A EP2819655B1 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
PL13715263T PL2819655T3 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
UAA201409664A UA113301C2 (en) | 2012-02-28 | 2013-02-25 | APPLICATION OF MODAFINIL IN THE TREATMENT OF Cocaine ADDITIONAL PATIENTS |
NZ628009A NZ628009A (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
KR1020147023180A KR101897855B1 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
IN7831DEN2014 IN2014DN07831A (en) | 2012-02-28 | 2013-02-25 | |
PT137152633T PT2819655T (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
ES13715263.3T ES2593276T3 (en) | 2012-02-28 | 2013-02-25 | Use of Modafinil in the treatment of cocaine addicts |
DK13715263.3T DK2819655T3 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
RS20160882A RS55238B1 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
CN201380011342.7A CN104159575B (en) | 2012-02-28 | 2013-02-25 | Application of the modafinil in treating cocainomaniac |
EA201400960A EA025692B1 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
BR112014020626A BR112014020626A2 (en) | 2012-02-28 | 2013-02-25 | modafinil application in the treatment of cocaine lovers |
LTEP13715263.3T LT2819655T (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
AU2013224831A AU2013224831B2 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
SG11201405316WA SG11201405316WA (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
US14/381,896 US20150073055A1 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
PCT/FR2013/000052 WO2013128088A1 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
HUE13715263A HUE030737T2 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
CA2863159A CA2863159C (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
MX2014010237A MX348222B (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts. |
SI201330319A SI2819655T1 (en) | 2012-02-28 | 2013-02-25 | Modafinil for use in the treatment of cocaine addicts |
JP2014559270A JP6163169B2 (en) | 2012-02-28 | 2013-02-25 | Use of modafinil in the treatment of cocaine addicts |
ARP130100596A AR090169A1 (en) | 2012-02-28 | 2013-02-27 | APPLICATION OF MODAFINILO |
TW102106817A TWI626042B (en) | 2012-02-28 | 2013-02-27 | Pharmaceutical composition of modafinil in the substitution treatment of cocaine addicts |
IL234009A IL234009B (en) | 2012-02-28 | 2014-08-07 | Compositions comprising s-modafinil for use in substitution treatment of cocaine addicts |
ZA2014/05910A ZA201405910B (en) | 2012-02-28 | 2014-08-12 | Use of modafinil in the treatment of cocaine addicts |
PH12014501837A PH12014501837A1 (en) | 2012-02-28 | 2014-08-14 | Use of modafinil in the treatment of cocaine addicts |
CL2014002203A CL2014002203A1 (en) | 2012-02-28 | 2014-08-19 | Use of modafinil in the treatment of cocaine substitution; Oral pharmaceutical composition containing Modafinil in the form of its dextrogiro enantiomer. |
HRP20161165TT HRP20161165T1 (en) | 2012-02-28 | 2016-09-12 | Modafinil for use in the treatment of cocaine addicts |
SM201600363T SMT201600363B (en) | 2012-02-28 | 2016-10-12 | MODAFINIL FOR USE IN THE TREATMENT OF COCAINOMANS |
CY20161101079T CY1118166T1 (en) | 2012-02-28 | 2016-10-26 | MODAFINILI FOR USE IN REDUCTION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1200581A FR2987267B1 (en) | 2012-02-28 | 2012-02-28 | APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2987267A1 FR2987267A1 (en) | 2013-08-30 |
FR2987267B1 true FR2987267B1 (en) | 2015-01-16 |
Family
ID=48083447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1200581A Expired - Fee Related FR2987267B1 (en) | 2012-02-28 | 2012-02-28 | APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES |
Country Status (33)
Country | Link |
---|---|
US (1) | US20150073055A1 (en) |
EP (1) | EP2819655B1 (en) |
JP (1) | JP6163169B2 (en) |
KR (1) | KR101897855B1 (en) |
CN (1) | CN104159575B (en) |
AR (1) | AR090169A1 (en) |
AU (1) | AU2013224831B2 (en) |
BR (1) | BR112014020626A2 (en) |
CA (1) | CA2863159C (en) |
CL (1) | CL2014002203A1 (en) |
CY (1) | CY1118166T1 (en) |
DK (1) | DK2819655T3 (en) |
EA (1) | EA025692B1 (en) |
ES (1) | ES2593276T3 (en) |
FR (1) | FR2987267B1 (en) |
HR (1) | HRP20161165T1 (en) |
HU (1) | HUE030737T2 (en) |
IL (1) | IL234009B (en) |
IN (1) | IN2014DN07831A (en) |
LT (1) | LT2819655T (en) |
MX (1) | MX348222B (en) |
NZ (1) | NZ628009A (en) |
PH (1) | PH12014501837A1 (en) |
PL (1) | PL2819655T3 (en) |
PT (1) | PT2819655T (en) |
RS (1) | RS55238B1 (en) |
SG (1) | SG11201405316WA (en) |
SI (1) | SI2819655T1 (en) |
SM (1) | SMT201600363B (en) |
TW (1) | TWI626042B (en) |
UA (1) | UA113301C2 (en) |
WO (1) | WO2013128088A1 (en) |
ZA (1) | ZA201405910B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105055404B (en) * | 2015-08-19 | 2017-07-18 | 四川大学 | Purposes of the HMGCS2 inhibitor in the medicine for preparing treatment cocaine habituation |
CN105055412B (en) * | 2015-08-20 | 2018-06-19 | 四川大学 | Purposes of the NAMPT inhibitor in the drug for preparing treatment cocaine habituation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
FR2771004B1 (en) | 1997-11-19 | 2000-02-18 | Inst Curie | USE OF BENZHYDRYL SULFINYL DERIVATIVES FOR THE MANUFACTURE OF MEDICINAL PRODUCTS HAVING A WAKING EFFECT IN SITUATIONS OF DRUG-BASED VIGILANCE DISORDERS |
US20010034373A1 (en) | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
EP1330244B1 (en) * | 2000-10-11 | 2008-12-17 | Cephalon, Inc. | Compositions comprising modafinil compounds |
US20040006532A1 (en) | 2001-03-20 | 2004-01-08 | David Lawrence | Network access risk management |
US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
US7093476B2 (en) | 2004-09-15 | 2006-08-22 | Ut-Battelle, Llc | Method for fabricating thin californium-containing radioactive source wires |
WO2007013962A2 (en) * | 2005-07-21 | 2007-02-01 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
BRPI0714173A2 (en) * | 2006-07-12 | 2012-12-25 | Elan Pharma Int Ltd | stable nanoparticulate composition, methods for preparing the composition, for preventing and / or treating disease conditions, symptoms, syndromes and conditions of the central nervous system, for improving or maintaining bioavailability of modafinil, and for treating neurologically based disorder, pharmaceutical composition, and dosage form |
EP1980240A1 (en) * | 2007-04-11 | 2008-10-15 | Cephalon France | Lyophilized pharmaceutical compositions and methods of making and using same |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
-
2012
- 2012-02-28 FR FR1200581A patent/FR2987267B1/en not_active Expired - Fee Related
-
2013
- 2013-02-25 CN CN201380011342.7A patent/CN104159575B/en not_active Expired - Fee Related
- 2013-02-25 SI SI201330319A patent/SI2819655T1/en unknown
- 2013-02-25 MX MX2014010237A patent/MX348222B/en active IP Right Grant
- 2013-02-25 IN IN7831DEN2014 patent/IN2014DN07831A/en unknown
- 2013-02-25 NZ NZ628009A patent/NZ628009A/en not_active IP Right Cessation
- 2013-02-25 ES ES13715263.3T patent/ES2593276T3/en active Active
- 2013-02-25 DK DK13715263.3T patent/DK2819655T3/en active
- 2013-02-25 PL PL13715263T patent/PL2819655T3/en unknown
- 2013-02-25 AU AU2013224831A patent/AU2013224831B2/en not_active Ceased
- 2013-02-25 SG SG11201405316WA patent/SG11201405316WA/en unknown
- 2013-02-25 RS RS20160882A patent/RS55238B1/en unknown
- 2013-02-25 CA CA2863159A patent/CA2863159C/en not_active Expired - Fee Related
- 2013-02-25 EA EA201400960A patent/EA025692B1/en not_active IP Right Cessation
- 2013-02-25 KR KR1020147023180A patent/KR101897855B1/en active IP Right Grant
- 2013-02-25 UA UAA201409664A patent/UA113301C2/en unknown
- 2013-02-25 LT LTEP13715263.3T patent/LT2819655T/en unknown
- 2013-02-25 BR BR112014020626A patent/BR112014020626A2/en not_active Application Discontinuation
- 2013-02-25 HU HUE13715263A patent/HUE030737T2/en unknown
- 2013-02-25 WO PCT/FR2013/000052 patent/WO2013128088A1/en active Application Filing
- 2013-02-25 PT PT137152633T patent/PT2819655T/en unknown
- 2013-02-25 JP JP2014559270A patent/JP6163169B2/en not_active Expired - Fee Related
- 2013-02-25 US US14/381,896 patent/US20150073055A1/en not_active Abandoned
- 2013-02-25 EP EP13715263.3A patent/EP2819655B1/en active Active
- 2013-02-27 TW TW102106817A patent/TWI626042B/en not_active IP Right Cessation
- 2013-02-27 AR ARP130100596A patent/AR090169A1/en unknown
-
2014
- 2014-08-07 IL IL234009A patent/IL234009B/en active IP Right Grant
- 2014-08-12 ZA ZA2014/05910A patent/ZA201405910B/en unknown
- 2014-08-14 PH PH12014501837A patent/PH12014501837A1/en unknown
- 2014-08-19 CL CL2014002203A patent/CL2014002203A1/en unknown
-
2016
- 2016-09-12 HR HRP20161165TT patent/HRP20161165T1/en unknown
- 2016-10-12 SM SM201600363T patent/SMT201600363B/en unknown
- 2016-10-26 CY CY20161101079T patent/CY1118166T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222552A1 (en) | Sobetirome in the treatment of myelination diseases | |
DK2919796T3 (en) | USE OF AKKERMANSIA FOR THE TREATMENT OF METABLE DISEASES | |
BR112015003227A2 (en) | clicoconjugation processes and compositions | |
SG11201406408RA (en) | Purification of biological molecules | |
EP2831001A4 (en) | Water treatment compositions and methods of use | |
BR112014031223A2 (en) | polymer treatment compositions | |
BR112013024401A2 (en) | Methods and Compositions for the Treatment of Attention Deficit Disorder | |
DK2827813T3 (en) | COLD TREATMENT DEVICE | |
BR112014031086A2 (en) | treatment and prevention of cardiovascular disease and thrombosis | |
GB201506561D0 (en) | Treatment of amblyopia | |
FR20C1044I2 (en) | TRIAZINES FOR THE TREATMENT OF PROTOZOIC INFECTIONS | |
FR2977489B1 (en) | METHODS OF COSMETIC TREATMENT AND KIT | |
DK2892556T3 (en) | Compositions and methods for the treatment of diseases | |
FR2995777B1 (en) | METHOD OF CHARACTERIZING THE VOLUMES OF THE SKIN | |
DK2688588T3 (en) | QUICK AND LONG-TERM EFFECTIVE IMMUNOLOGICAL THERAPEUTIC AGENT | |
DK2646039T3 (en) | COMPOSITION AND ITS APPLICATION IN THE TREATMENT OF ANAL RHADA | |
FR3015285B1 (en) | FORMULATION FOR THE TREATMENT OF HAIR | |
FR3000491B1 (en) | COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | |
FR2993564B1 (en) | IMIDAZOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES | |
DK2950918T3 (en) | PROCESS UNIT AND USE OF SEVERAL PROCESS UNITS | |
FR2987267B1 (en) | APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES | |
BR112013023115A2 (en) | hair treatment composition | |
DK2694056T3 (en) | THERAPEUTIC TREATMENT | |
ITRM20120473A1 (en) | USE OF GLYCEROPHOSPHOINOSITOLS FOR THE TREATMENT OF SEPTIC SHOCK | |
FR3000399B1 (en) | TOPICAL USE OF LAROPIPRANT FOR THE TREATMENT OF ROSACEA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
ST | Notification of lapse |
Effective date: 20181031 |